NCT00117975 2016-07-06
Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Alliance for Clinical Trials in Oncology
Phase 2 Completed
Clinical Trials
4 trialsNCT00516217 2016-07-06
Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00048555 2013-09-16
Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma
Biogen
Phase 1/2 Completed
NCT00575068 2012-06-08
Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma
Biogen
Phase 1/2 Completed